| abstract |
<p> A PARVOVIRUS FORMULATION IS DESCRIBED THAT INCLUDES (A) AT LEAST LX 109 UFP / ML OF PARVOVIRUS H1 (H-1PV) OR A SELECTED RELATED PARVOVIRUS THAT CONSISTS OF LU III, MOUSE VIRUS MINUTE (MMV) MOUSE PARVOVIRUS (MPV), RAT MINUTE VIRUS (RMV), RAT PARVOVIRUS OR RAT VIRUS (RV) AND (B) A PHARMACEUTICALLY ACCEPTABLE VEHICLE CONTAINING 40 TO 50% LODIXANOL (P / V), 0.7 A 0, 9 MMOL OF CACL2 X 2 H20, 50 TO 60 MMOL OF NACI, 0.9 TO 1.2 MMOL OF KCI, 0.7 AC, 95 MG / ML OF TROMETAMINE AND 0.05 TO 0.15 MG / ML OF EDETATE DISODIC CALCIUM. A PREFERRED USE IS THE THERAPY OF A BRAIN TUMOR BY INTRATUMORAL INJECTION. </p> |